FindTrial
Sign In

A Study on Training Effect by Robot Suit HAL for Medical Use (Lower Limb Type) - Verification in patients with Parkinson's disease -

A Study on Training Effect by Robot Suit HAL for Medical Use (Lower Limb Type) - Verification in patients with Parkinson's disease - - A Study on Training Effect by Robot Suit HAL for Medical Use (Lower Limb Type) - Verification in patients with Parkinson's disease -

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000031551
Enrollment
30
Registered
2018-03-27
Start date
2018-03-27
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson&#39

Interventions

The HAL group takes at first the HAL period followed by the conventional period. In the HAL period, the patient performs 2 sets of rehabilitation of 5 days training with HAL for 60 minutes followed b

Sponsors

Nagoya City Rehabilitation Agency
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: -Patients diagnosed as clinically established or clinically probable Parkinson's disease with Movement Disorder Society (MDS) clinical diagnostic criteria -Patients who meet the stage 2-4 for Hoehn & Yahr staging scale -Patients who consent with full understanding -Patients judged that who are stable, and able to stand and walk -Patients with the ability to stand and walk more than 10 m without assistance -Patients' weight: 40 to 100 kg -Patients' heights: 150 to 190 cm

Exclusion criteria

Exclusion criteria: -Patients planned to change the dose of anti-Parkinson's disease drug -Patients judged as inappropriate for the walking training -Patients have difficulties with wearing HAL -Patients have difficulties with putting the electrodes on the skin -Patients during pregnancy -Patients have difficulties with understanding instructions

Design outcomes

Primary

MeasureTime frame
Timed up and Go test—

Secondary

MeasureTime frame
age, gender, height, weight, disease duration, HDS-R, Hoehn & Yahr staging scale, Classification according to clinical diagnostic criteria of Parkinson's disease by MDS, MDSUPDRS part III, freezingof gait questionnaire(FOG-Q), 10m gait speed, step length, Berg Balance Scale(BBS), Video—

Countries

Japan

Contacts

Public ContactYutaka Kondou

Nagoya City Rehabilitation Center Division of Physical Therapy

physical@nagoya-rehab.or.jp052-835-3811

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026